fbpx

The CONTACT-1 Study: A Study of Atezolizumab (immunotherapy) in combination with Cabozantinib verus Docetaxel (standard chemotherapy) in patients with previously treated metastatic Non-Small Cell Lung Cancer. For more information, please click here or phone (08) 9242 7640.